Screening for sexually transmitted diseases in an HIV testing clinic; uptake and prevalence

S Madge1, J Elford, M C Lipman

  • 1Department of Thoracic Medicine, Royal Free Hospital School of Medicine, Hampstead, London.

Genitourinary Medicine
|October 1, 1996
PubMed

Insights

Sexually transmitted disease (STD) prevalence was low among individuals seeking HIV testing, but undiagnosed hepatitis B infection was common. Opportunistic STD screening was acceptable to most, but selective screening may benefit those not previously tested.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • HIV testing clinics serve as a crucial point for identifying other infections.
  • Understanding the prevalence of sexually transmitted diseases (STDs) and vaccine-preventable infections like hepatitis B is vital in populations seeking HIV testing.

Purpose of the Study:

  • To determine the prevalence of STDs and hepatitis B infection.
  • To assess the acceptability of opportunistic STD screening among individuals attending an HIV testing clinic.

Main Methods:

  • A 9-month period prevalence study was conducted at a Same Day Testing Clinic (SDTC) for HIV antibodies.
  • 242 males and 160 females were recruited to assess the prevalence of gonorrhoea, chlamydia, syphilis, and hepatitis B, and their acceptance of STD screening.

Main Results:

  • The prevalence of acute STDs was low, with 2 cases of syphilis, 6 of chlamydia, 4 of herpes, and 3 of genital warts detected.
  • Undiagnosed hepatitis B infection was found in 26 individuals, with low hepatitis B vaccination uptake (28%) among eligible homosexual men.
  • HIV antibody positivity was 4% in males and 0% in females screened for STDs.

Conclusions:

  • While acute STD prevalence was low, undiagnosed hepatitis B infection was significant, highlighting a need for vaccination.
  • Opportunistic STD screening was acceptable to nearly two-thirds of attendees, with selective screening recommended for those untested.
  • Encouraging hepatitis B testing and vaccination is crucial for at-risk populations attending HIV testing services.
Abstract